XML 37 R11.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Fair Value Measurements
6 Months Ended
Jun. 30, 2011
Fair Value Measurements

Note 5. Fair Value Measurements

The Company measures certain financial assets at fair value on a recurring basis, including cash equivalents, short-term investments, and equity investments. The fair value of these financial assets was determined based on three levels of inputs:

 

   

Level 1: Observable inputs such as quoted prices in active markets for identical assets or liabilities

 

   

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active

 

   

Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions

 

Items Measured at Fair Value on a Recurring Basis

The following table presents information about the Company’s financial assets that have been measured at fair value on a recurring basis as of June 30, 2011, and December 31, 2010, and indicates the fair value hierarchy of the valuation inputs utilized to determine such fair value (in thousands).

 

     Fair Value Measurements as of
June 30, 2011
 
     Total      Level 1      Level 2      Level 3  

Cash equivalents:

           

Money market funds

   $ 31,075       $ 31,075       $ 0       $ 0   

Corporate notes and bonds

     126,398         126,398         0         0   

U.S. government agency securities

     4,200         4,200         0         0   

Short-term investments:

           

Corporate notes and bonds

     52,564         52,564         0         0   

U.S. government agency securities

     38,578         38,578         0         0   

Restricted cash equivalents and investments

     10,141         10,141         0         0   

Available for sale securities:

           

Publicly traded investments

     26,150         26,150         0         0   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 289,106       $ 289,106       $ 0       $ 0   
  

 

 

    

 

 

    

 

 

    

 

 

 
     Fair Value Measurements as of
December 31, 2010
 
     Total      Level 1      Level 2      Level 3  

Cash equivalents:

           

Money market funds

   $ 44,348       $ 44,348       $ 0       $ 0   

Corporate notes and bonds

     120,984         120,984         0         0   

U.S. Government agency securities

     3,700         3,700         0         0   

Short-term investments:

           

Corporate notes and bonds

     76,157         76,157         0         0   

U.S. government agency securities

     22,146         22,146         0         0   

Restricted cash equivalents and investments

     10,000         10,000         0         0   

Available for sale securities:

           

Publicly traded investments

     27,541         27,541         0         0   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 304,876       $ 304,876       $ 0       $ 0   
  

 

 

    

 

 

    

 

 

    

 

 

 

Investments in marketable securities classified as short-term investments and equity investments of public companies are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy. The Company carries its equity investments in private companies at cost and no fair value is derived on a recurring basis. The Company has consistently applied these valuation techniques in all periods presented.

Items Measured at Fair Value on a Nonrecurring Basis

Certain assets and liabilities of the Company are measured at estimated fair value on a non-recurring basis. These instruments are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The Company performed a valuation using Level 3 inputs of its investment in the Rhapsody joint venture as of March 31, 2010. The Company performed the analysis as a result of the restructuring and related deconsolidation of Rhapsody, which is further described in “Note 4, Rhapsody Joint Venture.” The fair value analysis used multiple valuation models and was based on assumptions of future results made by management, including operating and cash flow projections.